Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

4 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of a natural supplement containing glucosinolates, phytosterols and citrus flavonoids on body weight and metabolic parameters in a menopausal murine model induced by bilateral ovariectomy.
Valdivia M, Soto-Becerra P, Laguna-Barraza R, Rojas PA, Reyes-Mandujano I, Gonzáles-Reyes P, Temoche H, Timoteo OS, Lugo-Martinez G, Calzada-Mendoza CC, Mezones-Holguin E. Valdivia M, et al. Among authors: lugo martinez g. Gynecol Endocrinol. 2020 Dec;36(12):1106-1111. doi: 10.1080/09513590.2020.1821639. Epub 2020 Sep 21. Gynecol Endocrinol. 2020. PMID: 32954883
Safety and tolerability of a natural supplement containing glucosinolates, phytosterols and citrus flavonoids in adult women: a randomized phase I, placebo-controlled, multi-arm, double-blinded clinical trial.
Villar-López M, Soto-Becerra P, Curse Choque R, Al-Kassab-Córdova A, Bernuy-Barrera F, Palomino H, Rojas PA, Vera C, Lugo-Martínez G, Mezones-Holguín E. Villar-López M, et al. Among authors: lugo martinez g. Gynecol Endocrinol. 2021 Oct;37(10):906-913. doi: 10.1080/09513590.2021.1960965. Epub 2021 Aug 11. Gynecol Endocrinol. 2021. PMID: 34379025 Clinical Trial.
Short-term effects and safety of a natural oral supplement containing glucosinolates, phytosterols, and citrus flavonoids compared with hormone treatment for the management of postmenopausal symptomatic women: a pilot single-center randomized phase 2 clinical trial.
Villar-López M, Soto-Becerra P, Chedraui P, Osorio-Manyari JD, Al-Kassab-Córdova A, Osorio-Manyari AA, Fernandez-Sosaya JL, Moya-Silvestre E, Rojas PA, Lugo-Martínez G, Mezones-Holguín E. Villar-López M, et al. Among authors: lugo martinez g. Menopause. 2023 Dec 1;30(12):1230-1240. doi: 10.1097/GME.0000000000002268. Epub 2023 Oct 24. Menopause. 2023. PMID: 37874969 Clinical Trial.